Occam Places Two Board Members at George Church Biotech
In August 2025, Occam Global recruited Doug Williams, PhD, and Adam Craig, MD, PhD, to the eGenesis board.
Douglas Williams, PhD, is a senior R&D leader with over 30 years of experience gained at Biogen, ZymoGenetics, Amgen, and Seagen, and has contributed to such notable therapies as Enbrel®, Tecfidera®, and Spinraza®. Williams was President of R&D at Sana Biotechnology and founding CEO of Codiak Biosciences. He now chairs Climb Bio and serves on the board of CAMP4 Therapeutics.
Adam Craig, MD, PhD, brings 25+ years of drug development and commercialization expertise in oncology, hematology, and rare diseases. As CEO of CTI BioPharma, he led Vonjo® to approval and commercialization and then sold that company to Swedish Orphan Biovitrum AB (Sobi) in 2023 for ~$1.7 billion. He now serves as Executive Chairman of X4 Pharmaceuticals and as a member of Stratus Therapeutics’ board.
About eGenesis
eGenesis isa George Church company pioneering a genome engineering-based approach to develop safe and effective transplantable organs, ultimately ending the global organ shortage. In the last year, the company has successfully completed two porcine-human kidney transplants and is utilizing funds from a recently closed $191M Series D round to advance programs in the heart, liver, and kidney to the clinic. Investors include Lux Capital, ARCH Ventures, Khosla Ventures, Farallon Capital Management, Leaps by Bayer, Polaris Partners, Catalio Capital Management, and Osage University Partners.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.